Targeting Uremic Toxins in Chronic Kidney Disease: Current Challenges and Emerging Therapeutic Strategies

Area of Science:

• Nephrology
• Toxicology
• Microbiology

Background:

• Chronic kidney disease (CKD) is a major health issue linked to high mortality, primarily from cardiovascular diseases.
• Impaired kidney function in CKD leads to the accumulation of uremic toxins, affecting multiple organ systems.
• Uremic toxins promote cardiovascular disease via inflammation, oxidative stress, and endothelial dysfunction, contributing to atherosclerosis.

Purpose of the Study:

• To provide a comprehensive review of uremic toxicity in CKD.
• To explore the pathophysiological mechanisms of uremic toxin accumulation.
• To examine the role of gut microbiota in uremic toxicity and discuss emerging interventions.

Main Methods:

• Literature review of existing research on chronic kidney disease and uremic toxins.
• Analysis of the pathophysiological pathways involved in uremic toxicity.
• Investigation of the gut microbiota's role and its metabolic contribution to uremic toxins.

Main Results:

• Uremic toxins contribute to cardiovascular disease, neurological impairment, bone disorders, and sarcopenia.
• Dietary components and gut microbiota metabolism are significant sources of uremic toxins.
• Current dialysis methods offer only partial mitigation of uremic toxicity.

Conclusions:

• Uremic toxins play a critical role in CKD progression and associated complications.
• Targeting uremic toxin generation, particularly from gut microbiota, is crucial.
• Development of novel strategies and improved dialysis modalities is necessary to effectively manage uremic toxicity.